Page last updated: 2024-12-06

spirorenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Spirorenone is a synthetic steroidal aldosterone antagonist. It is used to treat high blood pressure and edema associated with heart failure. Spirorenone is synthesized through a multi-step process involving a series of reactions including cyclization and oxidation. Its mechanism of action involves blocking the action of aldosterone, a hormone that regulates sodium and potassium levels in the body. By inhibiting aldosterone, spirorenone helps to reduce blood pressure and fluid retention. Spirorenone has been studied extensively for its potential to treat a variety of conditions, including heart failure, kidney disease, and even certain types of cancer. Its importance lies in its ability to effectively manage blood pressure and fluid balance, contributing to improved cardiovascular health.'

spirorenone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68923
CHEMBL ID2107584
MeSH IDM0107873

Synonyms (19)

Synonym
74220-07-8
zk-35973
spirorenone
delta-1-msp
CHEMBL2107584
spirorenonum
einecs 277-770-1
unii-b8tev07170
spirorenone [inn]
espirorenona [inn-spanish]
b8tev07170 ,
(6r,7r,8r,9s,10r,13s,14r,15s,16s,17s)-3',4',6,7,8,9,11,12,13,14,15,16,20,21-tetradecahydro-10,13-dimethylspiro(17h-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'h)-furan)-3(10h),5'-dione
spirorenonum [inn-latin]
spiro(17h-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'h)-furan)-3,5'(10h)-dione, 3',4',6,7,8,9,11,12,13,14,15,16,20,21-tetradecahydro-10,13-dimethyl-, (6r-(6alpha,7alpha,8beta,9alpha,10beta,13beta,14alpha,15alpha,16alpha,17beta))-
espirorenona
NZUIUYWHFPQZBH-HXCATZOESA-N
Q27274514
(1r,2r,4r,10r,11s,14s,15s,16s,18s,19s)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadeca-5,8-diene-15,5'-oxolane]-2',7-dione
DTXSID501024537

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" This compound accumulated considerably after multiple dosing and the area under the plasma concentration-time curve increased from 16 to 52% relative to that of spirorenone itself."( Pharmacokinetics of the new aldosterone antagonist, spirorenone, in healthy volunteers after single and repeated daily doses.
Krause, W; Sack, C; Seifert, W, 1983
)
0.71
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's1 (10.00)18.2507
2000's0 (0.00)29.6817
2010's2 (20.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]